<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04639544</url>
  </required_header>
  <id_info>
    <org_study_id>P049</org_study_id>
    <nct_id>NCT04639544</nct_id>
  </id_info>
  <brief_title>Effect of a Lactobacillus Strain on the Prevention of Recurrent Vaginal Candidiasis</brief_title>
  <official_title>Randomized, Triple-blind, Parallel-group Study to Evaluate the Effect of Consuming a Lactobacillus Strain on the Prevention of Recurrent Vaginal Candidiasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biosearch S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biosearch S.A.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the efficacy of the consumption of the one&#xD;
      probiotic strain in the prevention of new vaginal candidiasis events in women with recurrent&#xD;
      vaginal candidiasis. This is a preliminary study whose purpose is to know if this probiotic&#xD;
      is effective in reducing the number of candidiasis events and / or increasing the time&#xD;
      between possible relapses in women diagnosed with RVVC.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies have demonstrated the effectiveness of certain probiotic strains in the&#xD;
      treatment of vaginal candidiasis, alone or as an adjunct to antifungal treatments, as well as&#xD;
      the effectiveness of a Lactobacillus strain as maintenance treatment after antifungal&#xD;
      treatment to reduce the recurrence rate of candidiasis However, to date, no studies have&#xD;
      evaluated the oral efficacy of a probiotic strain of Lactobacillus originally isolated from&#xD;
      breast milk in the prevention of new vaginal yeast events in women with recurrent vaginal&#xD;
      yeast infections.&#xD;
&#xD;
      The objective of this study is to evaluate the efficacy of the consumption of the one&#xD;
      probiotic strain in the prevention of new vaginal candidiasis events in women with recurrent&#xD;
      vaginal candidiasis. This is a preliminary study whose purpose is to know if this probiotic&#xD;
      is effective in reducing the number of candidiasis events and / or increasing the time&#xD;
      between possible relapses in women diagnosed with RVVC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of candidiasis events</measure>
    <time_frame>6 months</time_frame>
    <description>Total candidiasis events during intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time between episodes</measure>
    <time_frame>6 months</time_frame>
    <description>Days from baseline until candidiasis events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of Candida in vaginal exudate by culture analysis</measure>
    <time_frame>6 months</time_frame>
    <description>Analysis of the presence of Candida in vaginal exudate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiota of vaginal exudate</measure>
    <time_frame>6 months</time_frame>
    <description>Load of Candida, Lactobacillus, Gardnerella, Prevotella, Streptococcus and Bacteroides species in vaginal exudate samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gynecological examination</measure>
    <time_frame>6 months</time_frame>
    <description>The gynecologist will perform a gynecological examination to check:Presence of erythema of the vulva, erythema of the vaginal mucosa, lumpy, whitish-coloured vulvar oedema and excoriation of the vulva</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pH of vaginal discharge</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of the pH of vaginal discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Test of related clinical symptoms</measure>
    <time_frame>6 months</time_frame>
    <description>The volunteers will complete a test about presence of vaginal itching, vaginal burning, whitish vaginal discharge, dysuria and dyspareunia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of the related clinical symptoms</measure>
    <time_frame>6 months</time_frame>
    <description>Intensity (mild, moderate, intense) of the related clinical symptoms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Recurrent Vulvovaginal Candidiasis</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Volunteers will take 1 capsule per day with maltodextrin for 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volunteers will take 1 capsule per day with the Lactobacillus strain for 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Each participant will consume 1 capsule per day in one of the main meals without any restriction in the diet or in their life habits</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus strain</intervention_name>
    <description>Each participant will consume 1 capsule per day in one of the main meals without any restriction in the diet or in their life habits</description>
    <arm_group_label>Probiotic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy women from 18 to 49 years old.&#xD;
&#xD;
          2. Having suffered at least four outbreaks of vaginal yeast infection in the last year.&#xD;
&#xD;
          3. Signed Informed Consent Form.&#xD;
&#xD;
          4. Agree to provide the scheduled samples.&#xD;
&#xD;
          5. Agree to perform gynecological examinations&#xD;
&#xD;
          6. Agree to report candidiasis events that occur during the study.&#xD;
&#xD;
          7. Ability to complete surveys.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Being currently consuming or having consumed a probiotic in the two weeks prior to the&#xD;
             study.&#xD;
&#xD;
          2. Being under antibiotic treatment at the time of beginning the study.&#xD;
&#xD;
          3. Being under pharmacological treatment for the treatment of candidiasis.&#xD;
&#xD;
          4. Have an allergy to an antibiotic&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Maldonado Lobón, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Biosearch S.A.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose Maldonado Lobón, PhD</last_name>
    <phone>+34 616556789</phone>
    <email>jamaldonado@biosearchlife.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Elena</name>
      <address>
        <city>Valdemoro</city>
        <state>Madrid</state>
        <zip>28342</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Cristina Fernandez Romero, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 16, 2020</study_first_submitted>
  <study_first_submitted_qc>November 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2020</study_first_posted>
  <last_update_submitted>January 21, 2021</last_update_submitted>
  <last_update_submitted_qc>January 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Recurrent Vulvovaginal Candidiasis</keyword>
  <keyword>Prevention</keyword>
  <keyword>Probiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Candidiasis</mesh_term>
    <mesh_term>Candidiasis, Vulvovaginal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

